Diabetes, HbA1c Linked to Adverse Outcomes After Surgery
For surgical inpatients aged ≥54 years, diabetes and increased hemoglobin A1c (HbA1c) are associated with increased risk of adverse outcomes, according to a study published online March Read more
Diabetes: Body fat percentage, not BMI, predicts risk
A new study suggests that the standard body mass index cannot accurately predict someone’s risk of developing type 2 diabetes or prediabetes. Source: Diabetes: Body fat percentage, Read more
Duodenum May Help Fight Metabolic Disease
Manipulating duodenal features from bile acids to neurons may offer new insight into obesity and type 2 diabetes Source: Duodenum May Help Fight Metabolic Read more
Class of type 2 diabetes drugs doesn’t cut death risk compared to placebo
Comparing three classes of type 2 diabetes drugs, researchers found one class, which includes Onglyza and Januvia, did not reduce death risk. Source: Class of type 2 diabetes drugs Read more
Artificial Pancreas Treatment Efficacious for Type 1 Diabetes
Increased time in the near normoglycemic range and reduced time in hypo- and hyperglycemia Source: Artificial Pancreas Treatment Efficacious for Type 1 Read more
One-Hour Plasma Glucose Useful Predictor of Diabetic Retinopathy
The one-hour test is as effective as the two-hour test in its predictive ability Source: One-Hour Plasma Glucose Useful Predictor of Diabetic Read more
Economic Costs of Diabetes in the U.S. in 2017
This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2017. Source:Economic Costs of Diabetes in the U.S. in Read more
Promising Early Study Results for the First GLP-1 Pill for Type 2 Diabetes
Trial shows that a pill version of Ozempic (semaglutide) can lower A1c by as much as 1.5% and also support weight loss. Source: Promising Early Study Results for the First GLP-1 Pill for Read more
FDA Panel Gives Thumbs Up to 90-Day Glucose Monitor
Unanimous agreement that device is safe and effective. The FDA’s Clinical Chemistry and Clinical Toxicology Devices Panel voted 8-0 in three separate questions that the Eversense device appeared to be safe and effective, and that its benefits outweighed the risks Source: FDA Panel Gives Thumbs Up to 90-Day Glucose Read more
Kidney disease symptoms present prior to type 2 diabetes diagnosis, study finds
A large number of people diagnosed with type 2 diabetes show symptoms of chronic kidney disease (CKD) before their diabetes diagnosis, researchers report. People with diabetes face an Read more